AGP Executive Report
Last update: 8 hours agoCancer Drug Access: The NPPA has revised prices for 543 anti-cancer medicine brands, with cuts of up to 93% taking effect November 9; some high-cost, single-source medicines are excluded. Meanwhile, a flood-damaged Pfizer plant in Gujarat is not expected to reopen until 2028, prolonging shortages of several chemotherapy drugs. Medicine Safety: The government has barred imports of medicines with less than a year of shelf life remaining. Pharma Exports: India’s drug exports rose 4.9% to $16.14 billion in the first half of FY27, led by stronger shipments to Europe as exports to North America slipped. Mental Health: Fortis psychiatrist Samir Parikh says three-quarters of people experiencing mental health difficulties still do not seek professional help.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
